Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - ASP, Sales Volume by Application The global point-of-care ultrasound market will witness a robust CAGR of 5.7%, valued at $3.01 billion in 2021, and expected to appreciate and reach $3.24 billion in 2022 and $5.9 Bn by 2030, confirms Strategic Market Research. Primary care doctors use point-of-care ultrasound as a medical treatment for a plethora of conditions ranging from acute appendicitis to AAA (abdominal aortic aneurysm). It generally refers to portable ultrasonography for the purpose of diagnostic and therapeutic processes. Point-of-care ultrasound devices are also called PoCUS devices. Point-of-care ultrasound is the first imaging tool to evaluate women with acute pelvic pain and help to understand pain management with alternatives. It can be thoroughly utilized for physiological monitoring, like preload, hemodynamic assessment, cardiac function (R.V.F. and L.V.F.), afterload, and volume status. It can be used in I.C.U.s and applied in several clinical situations to monitor therapeutic conditions in emergency care and to investigate internal or external pathological findings. It has many advantages over traditional methods, including improving patient outcomes, and reducing costs, mortality rates, and medical risk scenarios. Anesthesia providers need to understand different applications for POCUS, including focused cardiac ultrasound (FoCUS) and lung ultrasound (L.U.S.). POCUS is also used to confirm an intrauterine pregnancy, fetal viability, number of foetuses (twins/triplets), and gestational age. Additionally, this method provides physicians or clinicians with real-time info to manage and treat injured patients during emergencies, military medicine, and remote care facilities. As per the article by the National Library of Medicine with the title "Point-of-care ultrasound (POCUS): unnecessary gadgetry or evidence-based medicine," the accuracy of clinical examination versus ultrasound guidance for determining a safe procedure site showed that 15% of sites determined by clinical examination were unsafe for the pleural procedure. In comparison, ultrasound marked a safe site in 80% of these cases. In 33% of cases clinical investigation failed to find a safe site, but ultrasound was successfully able to do it in 54% of cases. Overall, ultrasound surged the total rate of accurate sites by 26%. Moreover, an increase in the incidences of target diseases and infectious diseases among the population, a rise in demand for P.O.C. tests, rapid technological advancements, and increased patient admission in emergency care are driving the market's growth. Market Drivers - Increase in the number of patient visits to Emergency care with various health problems, rise in the aging population, and increase in the prevalence of chronic diseases. • The increase in the number of patient visits to Emergency care with various health problems such as acute abdominal pain, Dyspnea, urology problems, problems in the Urinary bladder, Pulmonary Embolism, Thoracic Injuries, undifferentiated shock, cardiac arrest resuscitation, pulmonary embolism, pericardial effusion, inflammation, muscle spasm, and chest pain is expected to foster market growth as time progresses. According to the Healthcare and Utilization Project report, about 50,000 people per 1,00,000 cases made emergency department visits in 2020. PoCUS is an effective E.D. diagnostics tool for pathologies that presents abdominal pain. As per the C.D.C., in 2021, the number of visits by patients suffering from abdominal pain in the emergency department (E.D.) was about 31.8 percent. • A continuous increase in the number of old-age netizens is augmenting the growth of the PoC-ultrasound-devices market as they are more susceptible to diseases. The United Nations (U.N.) population reported that people aged 65 and above were about 727 million globally in 2020 and can grow up to 1.5 billion by 2050. Not all aged people can visit a medical care facility each time, and hence, these devices can be brought to these patients at their disposal for diagnosis. • The increasing demand for diagnosis and treatment due to the rise in the number of chronic diseases, such as Acute Coronary Syndrome, Aortic Aneurysm, Cholecystitis, etc., is the key factor that is driving the PoCUS market. An Ultrasound not only detects the disease but is also used for treatment purposes, like ultrasound-guided surgeries. The World Health Organization (WHO) reported that heart disease estimated mortality rate is around 17.9 million, and the cancer mortality rate is 9.6 million people each year, thus driving the demand for ultrasound procedures. • An increase in the birth rate worldwide is one of the vital factors that will drive the point-of-care ultrasound market. The United Nations world population prospects regarding the global birth rate in 2021 were 17.873 births per 1000 people, while the birth rate for India is 17.4 per 1000 people. Restraints – High cost of products and lack of skilled professionals • High costs associated with the products, unfavourable reimbursement policies in developing and under-developed economies, stringent regulatory policies, and lack of skilled professionals in emerging countries are the factors restraining the market's growth. Opportunities- Advancements in the technology • The technological advancements in the procedures such as Echocardiography, Pericardiocentesis, Thoracostomy, Tomography, vascular access, thoracentesis, arthrocentesis, and the growing demand for mobile point of care devices such as venous catheterization, peripheral venous catheterization to improve operational efficiency and patient health provides ample opportunities for the market to grow throughout the forecasted time period. Moreover, promotional initiatives undertaken by numerous organizations to increase the usage of point-of-care ultrasound systems and educate professionals from all specialties are also fuelling market growth opportunities. • Moreover, machine learning and deep learning has come into the picture & they are expected to lead the future growth of the market as new start-ups are getting huge funding for the development of POC ultrasound systems. For example, Echo Nous, a USA-based start-up, has developed an AI-powered ultrasound tool that raised an amount of USD 57 Million in 2022. Earlier in 2021, the start-up received USD 60 million for Kosmos, an AI-guided POC ultrasound s/y that can form high-quality images of the heart along with the other parts of the body of Homo sapiens. • Furthermore, the worldwide governments are sheer-focusing on the development of POC ultrasound systems and hence are spending a hefty amount of money on the same. Thus, the quality of these ultrasound systems is expected to improvise rapidly, thereby catering to extensive opportunities for market growth as time progresses. Global point of care ultrasound Market: - Analysis of different Segmentations: The Global PoC Ultrasound Market is segmented based on Type, Portability, Applications, End-User, and Region. Based on Device Type Therapeutic Diagnostic Based on Portability Hand-held devices Trolley-based devices Based on Application Emergency medicine Gynaecology & Obstetrics Cardiology Musculoskeletal Vascular surgery Urology Others Based on End-User Hospitals Maternity centers Clinics ASCs Others Based on Regions: North America • U.S. • Mexico • Canada • Rest of North America Europe • France • Germany • U.K • Spain • Italy • Rest of Europe Asia Pacific • China • India • South Korea • Japan • Australia • Rest of APAC LAMEA • Brazil • Saudi Arabia • Uruguay • Argentina • Rest of LAMEA Based on Device Type, the diagnostic segment dominated the overall market with a share of 65 percent in 2020 and is expected to continue its dominance all over the forecasted period. This is due to the increasing prevalence of chronic diseases worldwide. No severe risk is involved in using diagnostic ultrasound as it uses low-power sound waves, and using ultrasound for the diagnostic procedure is cost-effective over other medical imaging technologies. Based on Portability, the handheld devices segment dominated the overall market with a total valuation of USD 1 billion in 2020. Due to the rising demand by primary care physicians, manufacturing organizations have lowered the cost of the device. These are ultra-portable devices that can be used at hospitals, remote healthcare settings, and ASCs for diagnostic and therapeutic processes. Handheld ultrasound devices are operated by various customer groups, ranging from emergency medicine physicians to cardiologists. In the month of September 2022 Philips received FDA 510(k) clearance for its Portable Ultrasound 5000 compact series that decreases the need for costly as well as time consuming repeat scans. Having huge range of clinical capabilities, wireless connectivity and real time collaboration with reporting, the Philips Ultrasound 5000 compact series is one of the most robust, reliable and compact systems. It is frequently used by office-based physicians in various medical specialties, such as urology and gastroenterology, and helps physicians with quick patient examinations and initial screening. Based on Applications, the Emergency Medicine segment dominated the market in 2020. This is due to the rising adoption of emergency diagnostic tools in emergency care centers. The ultrasound scan can be performed directly at the time of physical examination within minutes, providing an answer to several clinical questions and reducing the number of active differential diagnoses. As per the Northern Ireland statistics for emergency care, the number of incidents recorded was about 1, 87,740 in 2020. The median waiting duration from arrival at an E.D. to an initial assessment by a medical professional was 12 minutes. Based on End Users, the hospitals' segment held a share of more than 50 percent and a CAGR of 5.5 percent in 2020. This is due to the factors such as the increasing no of emergency visits to hospitals with mild to severe conditions of thoracic/ abdominal trauma, abdominal pain, pleural effusion, cardiac arrest, and the rising demand for point-of-care systems. As per the American Hospital Association, United States 2020, the total number of hospitals in the United States is 6093, including community hospitals and federal government hospitals that uses ultrasound systems. Moreover, multiple usage of PoCUS as therapeutics, diagnostics, and guiding devices across various procedures are driving the segment's overall growth. Based on Regions, North America held the largest market share of 33 percent in 2020. The highest percentage of the North American region is due to an increase in funding by the government and industries for research and development in ultrasound systems, the rising prevalence of chronic diseases, an increase in technological advancements, the presence of established market players, and developed healthcare infrastructure in the region. As per the C.D.C., 6 in 10 Americans suffer from at least one chronic disease. These diseases cost the healthcare system $216 billion per year and cause $147 billion in lost productivity. Point of Care Ultrasound Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 3.1 Billion The total forecast of revenue in 2030 USD 5.9 Billion CAGR (2020-2030) 7.68% The base year for estimation 2020 Historical data 2017 - 2020 Segmentation By Device Type, By Portability, By End User, By Application, and By Region/Geography. By Device Type Therapeutic & Diagnostic By Portability Trolley-based devices and Handheld devices By Application Emergency medicine, Gynaecology & Obstetrics, Vascular Surgery, Urology, Musculoskeletal, and Cardiology By End-User Hospitals, Maternity centers, Clinics and ASCs By Region North America, Europe, Asia Pacific, and LAMEA Country Scope U.S., Canada, France, Germany, U.K., China, Japan, India, South Korea, Mexico, Brazil, U.A.E., etc. Company Usability Profiles G.E. Healthcare, FUJIFILM Sonosite, Inc., Koninklijke Philips N.V., Hitachi Ltd., ALPINION MEDICAL SYSTEMS Co., Ltd., EDAN Instruments, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Terason Corporation, Healcerion, CHISON Medical Technologies, Bard Access Systems Inc., Butterfly Network, Inc., Advanced Instrumentations, Teknova Medical Systems Co., Ltd., DRAMINSKI S. A., D.R.E. Medical, Shenzhen AnaSonic Bio-Medical Technology Co., Ltd. and Landwind Medical Global POC Ultrasound Market: Competitive Landscape Analysis The competitive landscape analysis provides information about the crucial competitors prevailing in the worldwide market environment. The comparison is performed based on key development strategies, market share, overall revenue generation, market ranking analysis, company overview, market initiatives, investment in R&D, company financials, organization weaknesses and strengths, global presence, production sites, production capacity, market potential, etc. The major competitors in the market are: G.E. Healthcare Shenzhen Mindray Bio-Medical Electronics Co., Ltd. FUJIFILM Sonosite, Inc. Koninklijke Philips N.V. Hitachi Ltd. ALPINION MEDICAL SYSTEMS Co., Ltd. EDAN Instruments Terason Corporation Healcerion Butterfly Network, Inc. Bard Access Systems Inc. Advanced Instrumentations D.R.E. Medical Teknova Medical Systems Co., Ltd. DRAMINSKI S. A. Landwind Medical CHISON Medical Technologies Recent Developments In the month of September 2022, Fujifilm Sonosite Inc., one of the market leaders in POCUS (Point of Care Ultrasound Systems), enhanced its next generation POCUS portfolio with the introduction of its new Sonosite LX systems in the European territory equipped with a high-tech clinical display system. This clinical display enables some of the most user-friendly touchscreen controls for improvisation of workflow efficacy thereby allowing clinicians to keep an eye on the images during the time of adjustments. Apart from this, the organization also introduced Cardiac Resuscitation & T8-3 Trans oesophageal transducer for guiding the clinicians to use TOU (Trans oesophageal Ultrasound) at POC. Both of the afore-mentioned factors are especially designed to be used with Sonosite PX & Sonosite LX respectively. • In the month of July 2022, GE Healthcare unveiled its highly advanced Voluson Expert 22 ultrasound system. This valuable addition to GE Healthcare’s Women Health portfolio resulted in an adequate utilization of graphic-based beam technology which is capable of producing images of exceptional quality and also offers a vast range of flexibility for a plethora of imaging functions. The clinicians reported that Voluson Expert 22 will improvise the point of care technological aspects extensively for pregnancy imaging. • Recently, the newest general imaging diagnostic ultrasound system, the Resona I9, was released by Mindray, a top global developer and supplier of medical devices and solutions. It delivers exceptional efficiency and a remarkable user experience while giving clinicians accurate and prompt responses. It was created using an ultrasound system with the newest technologies and in-depth clinical scenario insights from Mindray. Resona I9 has a programmable control panel, a longer battery life, a folding construction that can reach a height of one meter, and a super silent design that all work to make scanning less taxing. • Butterfly Network, Inc. launched the next-generation product, Butterfly iQ+, featuring the world's only Ultrasound-on-Chip technology by delivering high- grade performance along with sharp & fast imaging and unparalleled efficacy. It offers new capabilities, like Needle VizTM technology, faster frame rates, industry-leading durability, and longer battery life. Butterfly iQ+ features an optimized manufacturing process in partnership with TSMC, the world's largest and most advanced dedicated I.C. foundry. Various leading point-of-care ultrasound products that key market leaders develop Name of the product Function Key Players ACUSON P500 Ultrasound System A portable ultrasound system that is used to equip clinicians with highly efficient clinical applications as well as facilitate accurate diagnosis, and assist procedures in critical and emergency care. SIEMENS TE7 Max Ultrasound System It is designed to maximize capabilities in demanding Point of Care environments with its thoughtful industrial design and best-in-class image quality. Mindray LOGIQ P9 ultrasound system It is well suited for general imaging. Ranging from triage to comprehensive exams, LOGIQ P9 delivers consistent image quality, comprehensive application coverage, advanced features, and ease of use that enable timely, confident decisions. GE Healthcare Z.One PRO Ultrasound System It is a powerful and portable advanced point-of-care imaging platform that provides optimal B-mode and Doppler imaging for patients. Mindray Frequently Asked Question About This Report How big is the global point-of-care ultrasound market? The point-of-care ultrasound market share was USD 3.24 Bn in 2022 & is predicted to reach USD 5.9 billion by the year 2030. What is the global point of care ultrasound systems market growth? The point-of-care ultrasound system market growth is 7.68 percent throughout the forecasted period. How much is the Point of Care Ultrasound market worth? The point-of-care ultrasound market size was USD 3.01 Bn in 2021 & is predicted to reach USD 5.9 billion by 2030 with a CAGR of 7.68 percent. What was the worth of the North American Market in 2019? The North American market worth in 2019 was USD 283.9 million. What factors drive the demand for handheld point-of-care ultrasound devices? The factors that drive the demand for handheld devices are: • The rising demand by primary care physicians and manufacturing companies. • These devices can be used at hospitals, remote healthcare settings, and ASCs for diagnostic and therapeutic processes. • These are operated by various customer groups, emergency medicine physicians, and cardiologists. What is the point of care ultrasound market forecast period? The point-of-care ultrasound market forecast period is from 2021 to 2030. Sources https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334078/ https://www.macrotrends.net/countries/WLD/world/birth-rate https://www.cdc.gov/chronicdisease/about/costs/index.htm https://www.cdc.gov/nchs/products/databriefs/db43.htm https://pubmed.ncbi.nlm.nih.gov/32747085/#:~:text=Results%3A%20There%20were%2048%2C835%20clinically,per%20100%2C000%20population%20was%2014.9. https://eu.medical.canon/News/PressRelease/Detail/114119-834 https://wwww.mindray.com/au/news/details/20210709041111.html https://eu.medical.canon/News/PressRelease/Detail/64372-834 https://www.fujifilm.com/us/en/news/healthcare/sonosite-launches-new-point-of-care-ultrasound-system https://www.butterflynetwork.com/press-releases/butterfly-iq-pluss-press-release 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Point of Care Ultrasound Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Point of Care Ultrasound Market 4.2.1 market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 market, by region, 2021 - 2030 (USD Million) 4.4 By Device Type Business Analysis 4.4.1 market, By Device Type, 2021 - 2030 (USD Million) 4.5 By Portability Business Analysis 4.5.1 market, By Portability, 2021 - 2030 (USD Million) 4.6 End-user Business Analysis 4.6.1 market, By End-user, 2021 - 2030 (USD Million) 4.7 Application Business Analysis 4.7.1 market, By Application, 2021 - 2030 (USD Million) 4.8 Value Chain Analysis 4.9 Market Variable Analysis 4.9.1 Market Drivers Analysis 4.9.2 Market Restraints Analysis 4.10 Business Environment Analysis Tool 4.10.1 market PEST analysis 4.10.2 market Porter’s analysis 4.11 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Device Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Device Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Therapeutic 7.3.1. Therapeutic market, 2021 - 2030 (USD Million) 7.4. Diagnostic 7.4.1. Diagnostic market, 2021 - 2030 (USD Million) 8. Market: By Portability Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hand-held devices 8.3.1. Hand-held devices Market, 2021 - 2030 (USD Million) 9. Market: By End-user Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Hospitals 9.3.1. Hospitals market, 2021 - 2030 (USD Million) 9.4. Maternity centers 9.4.1. Maternity centers market, 2021 - 2030 (USD Million) 9.5. Clinics 9.5.1. Clinics market, 2021 - 2030 (USD Million) 9.5. ASCs 9.5.1. ASCs market, 2021 - 2030 (USD Million) 9.6. Others 9.6.1. Others market, 2021 - 2030 (USD Million) 10. Market: By Application Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Emergency medicine 10.3.1. Emergency medicine market, 2021 - 2030 (USD Million) 10.4. Gynaecology & Obstetrics 10.4.1. Gynaecology & Obstetrics market, 2021 - 2030 (USD Million) 10.5. Cardiology 10.5.1. Cardiology Market, 2021 - 2030 (USD Million) 10.6. Musculoskeletal 10.6.1. Musculoskeletal Market, 2021 - 2030 (USD Million) 10.6. Vascular surgery 10.6.1. Vascular surgery Market, 2021 - 2030 (USD Million) 10.6. Urology 10.6.1. Urology Market, 2021 - 2030 (USD Million) 10.6. Other 10.6.1. Other Market, 2021 - 2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North America market, By Device Type, 2021 - 2030 (USD Million) 11.1.2. North America market, By Portability, 2021 - 2030 (USD Million) 11.1.3. North America market, by Application, 2021 - 2030 (USD Million) 11.1.4. North America market, by Country, 2021 - 2030 (USD Million) 11.1.5. North America market, By Type, 2021 - 2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. market, By Device Type, 2021 - 2030 (USD Million) 11.1.4.1.2. U.S. market, By Portability, 2021 - 2030 (USD Million) 11.1.4.1.3. U.S. market, by Application, 2021 - 2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada market, By Device Type, 2021 - 2030 (USD Million) 11.1.4.2.2. Canada market, By Portability, 2021 - 2030 (USD Million) 11.1.4.2.3. Canada market, by Application, 2021 - 2030 (USD Million) 11.2. Europe 11.2.1. Europe market, By Device Type, 2021 - 2030 (USD Million) 11.2.2. Europe market, By Portability, 2021 - 2030 (USD Million) 11.2.3. Europe market, by Application, 2021 - 2030 (USD Million) 11.2.4. Europe market, by country, 2021 - 2030 (USD Million) 11.2.5. Europe market, By Type, 2021 - 2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. market, By Device Type, 2021 - 2030 (USD Million) 11.2.4.1.2. U.K. market, By Portability, 2021 - 2030 (USD Million) 11.2.4.1.3. U.K. market, by Application, 2021 - 2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany market, By Device Type, 2021 - 2030 (USD Million) 11.2.4.2.2. Germany market, By Portability, 2021 - 2030 (USD Million) 11.2.4.2.3. Germany market, by Application, 2021 - 2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France market, By Device Type, 2021 - 2030 (USD Million) 11.2.4.3.2. France market, By Portability, 2021 - 2030 (USD Million) 11.2.4.3.3. France market, by Application, 2021 - 2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe market, By Device Type, 2021 - 2030 (USD Million) 11.2.4.4.2. Rest of Europe market, By Portability, 2021 - 2030 (USD Million) 11.2.4.4.3. Rest of Europe market, by Application, 2021 - 2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific market, By Device Type, 2021 - 2030 (USD Million) 11.3.2. Asia Pacific market, By Portability, 2021 - 2030 (USD Million) 11.3.3. Asia Pacific market, by Application, 2021 - 2030 (USD Million) 11.3.4. Asia Pacific market, by country, 2021 - 2030 (USD Million) 11.3.5. Asia Pacific market, By Type, 2021 - 2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China market, By Device Type, 2021 - 2030 (USD Million) 11.3.4.1.2. China market, By Portability, 2021 - 2030 (USD Million) 11.3.4.1.3. China market, by Application, 2021 - 2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India market, By Device Type, 2021 - 2030 (USD Million) 11.3.4.2.2. India market, By Portability, 2021 - 2030 (USD Million) 11.3.4.2.3. India market, by Application, 2021 - 2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan market, By Device Type, 2021 - 2030 (USD Million) 11.3.4.3.2. Japan market, By Portability, 2021 - 2030 (USD Million) 11.3.4.3.3. Japan market, by Application, 2021 - 2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea market, By Device Type, 2021 - 2030 (USD Million) 11.3.4.4.2. South Korea market, By Portability, 2021 - 2030 (USD Million) 11.3.4.4.3. South Korea market, by Application, 2021 - 2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC market, By Device Type, 2021 - 2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC market, By Portability, 2021 - 2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC market, by Application, 2021 - 2030 (USD Million) 11.4. Latin America 11.4.1. Latin America market, By Device Type, 2021 - 2030 (USD Million) 11.4.2. Latin America market, By Portability, 2021 - 2030 (USD Million) 11.4.3. Latin America market, by Application, 2021 - 2030 (USD Million) 11.4.4. Latin America market, by country, 2021 - 2030 (USD Million) 11.4.5. Latin America market, By Type, 2021 - 2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil market, By Device Type, 2021 - 2030 (USD Million) 11.4.4.1.2. Brazil market, By Portability, 2021 - 2030 (USD Million) 11.4.4.1.3. Brazil market, by Application, 2021 - 2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico market, By Device Type, 2021 - 2030 (USD Million) 11.4.4.2.2. Mexico market, By Portability, 2021 - 2030 (USD Million) 11.4.4.2.3. Mexico market, by Application, 2021 - 2030 (USD Million) 11.4.4.3. Rest of Latin America 11.4.4.3.1. Rest of the Latin America market, By Device Type, 2021 - 2030 (USD Million) 11.4.4.3.2. Rest of the Latin America market, By Portability, 2021 - 2030 (USD Million) 11.4.4.3.3. Rest of the Latin America market, by Application, 2021 - 2030 (USD Million) 11.5. MEA 11.5.1. MEA market, By Device Type, 2021 - 2030 (USD Million) 11.5.2. MEA market, By Portability, 2021 - 2030 (USD Million) 11.5.3. MEA market, by Application, 2021 - 2030 (USD Million) 11.5.4. MEA market, by region, 2021 - 2030 (USD Million) 11.5.5. MEA market, By Type, 2021 - 2030 (USD Million) 12. Competitive Landscape 12.1 G.E. HEALTHCARE 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Solutions Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Solutions Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. FUJIFILM Sonosite, Inc. 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Solutions Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. KONINKLIJKE PHILIPS N.V. 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Solutions Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. Hitachi Ltd. 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Solutions Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. ALPINION MEDICAL SYSTEMS Co., Ltd. 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Solutions Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. EDAN INSTRUMENTS 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Solutions Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. TERASON CORPORATION 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Solutions Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Healcerion 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Solutions Portfolio Analysis 12.9.4. Business Strategy & Recent Development 12.10. Butterfly Network, Inc. 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Solutions Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. Butterfly Network, Inc. 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Solutions Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. Advanced Instrumentations 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Solutions Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. D.R.E. Medical 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Solutions Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.14. TEKNOVA MEDICAL SYSTEMS CO., LTD. 12.14.1. Company overview 12.14.2. Financial performance 12.14.3. Solutions Portfolio Analysis 12.14.4. Business Strategy & Recent Development 12.15. DRAMINSKI S. A. 12.15.1. Company overview 12.15.2. Financial performance 12.15.3. Solutions Portfolio Analysis 12.15.4. Business Strategy & Recent Development 12.16. Landwind Medical 12.16.1. Company overview 12.16.2. Financial performance 12.16.3. Solutions Portfolio Analysis 12.16.4. Business Strategy & Recent Development 12.17. CHISON Medical Technologies 12.17.1. Company overview 12.17.2. Financial performance 12.17.3. Solutions Portfolio Analysis 12.17.4. Business Strategy & Recent Development List of Tables (74 Tables) TABLE 1. MARKET, By Device Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR Therapeutic, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Diagnostic, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Services, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Software, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Systems, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET, By Portability, 2021-2030 (USD Million) TABLE 8. MARKET FOR Hand-held devices, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR TROLLEY-BASED DEVICES, BY REGION, 2021-2030 (USD Million) TABLE 10. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Emergency medicine, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Gynaecology & Obstetrics, BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Cardiology, BY REGION, 2021-2030 (USD Million) TABLE 14 MARKET FOR Musculoskeletal, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Vascular surgery, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Urology, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET FOR Other, BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET, By End-user, 2021-2030 (USD Million) TABLE 19. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR Maternity centers, BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET FOR Clinics, BY REGION, 2021-2030 (USD Million) TABLE 22. MARKET FOR ASCs, BY REGION, 2021-2030 (USD Million) TABLE 23. MARKET FOR Other, BY REGION, 2021-2030 (USD Million) TABLE 24. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA MARKET, By Device Type, 2021-2030 (USD Million) TABLE 27. NORTH AMERICA MARKET, By Portability, 2021-2030 (USD Million) TABLE 28. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 29. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 30. EUROPE MARKET, By Device Type, 2021-2030 (USD Million) TABLE 31. EUROPE MARKET, By Portability, 2021-2030 (USD Million) TABLE 32. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 34. ASIA-PACIFIC MARKET, By Device Type, 2021-2030 (USD Million) TABLE 35. ASIA-PACIFIC MARKET, By Portability, 2021-2030 (USD Million) TABLE 36. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 37. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 38. LAMEA MARKET, By Device Type, 2021-2030 (USD Million) TABLE 39. LAMEA MARKET, By End-user, 2021-2030 (USD Million) TABLE 40. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 41. G.E. HEALTHCARE: COMPANY SNAPSHOT TABLE 42. G.E. HEALTHCARE: OPERATING SEGMENTS TABLE 43. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: COMPANY SNAPSHOT TABLE 44. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: OPERATING SEGMENTS TABLE 45. FUJIFILM Sonosite, Inc.: COMPANY SNAPSHOT TABLE 46. FUJIFILM Sonosite, Inc.: OPERATING SEGMENTS TABLE 47. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT TABLE 48. KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS TABLE 49. Hitachi Ltd.: COMPANY SNAPSHOT TABLE 50. Hitachi Ltd.: OPERATING SEGMENTS TABLE 51. ALPINION MEDICAL SYSTEMS Co., Ltd. : COMPANY SNAPSHOT TABLE 52. ALPINION MEDICAL SYSTEMS Co., Ltd. : OPERATING SEGMENTS TABLE 53. EDAN INSTRUMENTS: COMPANY SNAPSHOT TABLE 54. EDAN INSTRUMENTS: OPERATING SEGMENTS TABLE 55. TERASON CORPORATION: COMPANY SNAPSHOT TABLE 56. TERASON CORPORATION: OPERATING SEGMENTS TABLE 57. Healcerion: COMPANY SNAPSHOT TABLE 58. Healcerion: OPERATING SEGMENTS TABLE 59. Butterfly Network, Inc.: COMPANY SNAPSHOT TABLE 60. Butterfly Network, Inc.: OPERATING SEGMENTS TABLE 61. Butterfly Network, Inc.: COMPANY SNAPSHOT TABLE 62. Butterfly Network, Inc.: OPERATING SEGMENTS TABLE 63. Advanced Instrumentations: COMPANY SNAPSHOT TABLE 64. Advanced Instrumentations: OPERATING SEGMENTS TABLE 65. D.R.E. Medical: COMPANY SNAPSHOT TABLE 66. D.R.E. Medical: OPERATING SEGMENTS TABLE 67. TEKNOVA MEDICAL SYSTEMS CO., LTD.: COMPANY SNAPSHOT TABLE 68. TEKNOVA MEDICAL SYSTEMS CO., LTD.: OPERATING SEGMENTS TABLE 69. DRAMINSKI S. A.: COMPANY SNAPSHOT TABLE 70. DRAMINSKI S. A.: OPERATING SEGMENTS TABLE 71. Landwind Medical: COMPANY SNAPSHOT TABLE 72. Landwind Medical: OPERATING SEGMENTS TABLE 73. CHISON Medical Technologies: COMPANY SNAPSHOT TABLE 74. CHISON Medical Technologies: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Device Type-Based Estimation Figure 6 Top 17 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Genome Editing, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Genome Editing, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Portability, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Device Type, 2019 vs. 2025 (USD Million) Figure 14 Market Share, By End-user, 2019 vs. 2025 (USD Million) Figure 15 Geographical Snapshot of the Market Figure 16 Emergency Medicine to Witness Higher CAGR in the Market for Application Segment during the Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in Market for End-user Driving during Forecast Period. Figure 17 Handheld Devices to Witness Higher CAGR in Market for Portability Driving during Forecast Period. Figure 17 Diagnostic to Witness Higher CAGR in Market for Device Type Driving during Forecast Period. Figure 18 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview